Author

Keith Shah

Institution: North Central Cancer Treatment Group

Observed institution: North Central Cancer Treatment Group

OpenAlex ID: A5047273993

Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study

2011 · Stephen M Ansell, Hui Tang, et al. · The Lancet Oncology · 154

A Phase II Study of Temsirolimus (CCI-779) in Combination with Rituximab in Patients with Relapsed or Refractory Mantle Cell Lymphoma.

2009 · Stephen M Ansell, Hui Tang, et al. · Blood · 9

Works count: 2

Citation count: 163

H-index: 2

I10-index: 1